Nephrol Dial Transplant (2003) 18: 1518-1525
© 2003 European Renal Association-European Dialysis and Transplant Association
Oxidative stress-related factors in Bartter’s and Gitelman’s syndromes: relevance for angiotensin II signalling
1 Department of Clinical and Experimental Medicine, Clinica Medica 4, University of Padova, Italy and 2 Department of Internal Medicine-Clinical Nutrition, University of California, Davis, CA, USA
Correspondence and offprint requests to: Lorenzo A. Calò, MD, Department of Clinical and Experimental Medicine, Clinica Medica 4, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy. Email: renzcalo{at}unipd.it
Background. Bartter’s and Gitelman’s syndromes (BS/GS) have a blunted Gq protein-mediated cell signalling despite high circulating angiotensin II (Ang II) levels. This is associated with reduced G
q gene expression, intracellular inositol trisphosphate and Ca++ release, PKC activity and cell reactivity. Ang II is a powerful stimulator of vascular oxidases but BS/GS patients show reduced total volatile LDL oxidation products and reduced LDL susceptibility to oxidation suggesting low level of oxidative stress. Therefore, we evaluated oxidative stress-related proteins in plasma and monocytes of patients with BS/GS, at baseline and after Ang II stimulation.
Methods. In two BS and seven GS patients, biochemically and genetically characterized, and in 10 age- and sex-matched control subjects, we measured total plasma antioxidant power (AOP), plasma peroxynitrite level and gene expression of the NADH/NADPH oxidase subunit p22phox, TGFß and haeme oxygenase-1 (HO-1) in circulating monocytes in basal condition and after stimulation with Ang II. Furthermore, we investigated the C242T polymorphism of p22phox, whose topography in a potential haeme-binding site suggests a role in the regulation of oxidative stress.
Results. AOP was higher in BS/GS patients than in controls (3.27 ± 0.95 mmol/l vs 1.05 ± 0.16, P = 0.002), together with higher plasma renin activity and aldosterone level (9.88 ± 4.64 vs 0.95 ± 0.08 nmol Ang I/h/ml, P < 0.0001; and 0.73 ± 0.13 vs 0.18 ± 0.01 nmol/l, P < 0.0001, respectively). The plasma peroxynitrite level was undetectable both in patients and controls. mRNA expression of p22phox and TGFß was reduced in BS/GS patients compared to controls [0.35 ± 0.08 vs 0.53±0.05 densitometric units (d.u.), P = 0.005, and 0.82 ± 0.07 vs 1.15 ± 0.25 d.u., P = 0.006, respectively]. HO-1 mRNA was increased in BS/GS patients in comparison to controls (0.88 ± 0.07 vs 0.78 ± 0.11 d.u., P = 0.037). After acute Ang II exposure, p22phox, TGFß and HO-1 gene expression significantly increased only in controls (from 0.59 ± 0.12 to 0.96 ± 0.11, P < 0.001, from 0.97 ± 0.1 to 1.27 ± 0.22, P < 0.008, and from 0.62 ± 0.1 to 0.82 ± 0.09, P < 0.001, respectively). Finally, C242T polymorphism of p22phox was undetectable.
Conclusions. The intracellular responses to Ang II mediated by reactive oxygen species are reduced in BS/GS patients. This may contribute to their vascular hyporeactivity.
Keywords: angiotensin II; atherosclerosis; signal transduction; vasoactive agents; vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A. Calo, M. Puato, S. Schiavo, M. Zanardo, C. Tirrito, E. Pagnin, G. Balbi, P. A. Davis, P. Palatini, and P. Pauletto Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2804 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A Calo, A. Naso, G. Carraro, M. L. Wratten, E. Pagnin, L. Bertipaglia, M. Rebeschini, P. A Davis, A. Piccoli, and C. Cascone Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1413 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Wieczorek-Surdacka, A. Surdacki, S. M. Bode-Boger, B. Schubert, and W. Sulowicz Elevated plasma asymmetric dimethyl-L-arginine in a patient with Gordon syndrome Nephrol. Dial. Transplant., January 1, 2007; 22(1): 268 - 271. [Full Text] [PDF]
|
|
|
|
|
|
E. Pagnin, P. A. Davis, A. Semplicini, and L. A. Calo The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2340 - 2342. [Full Text] [PDF]
|
|
|
|
|
|
L. A. Calo, E. Pagnin, M. Mussap, P. A. Davis, and A. Semplicini Rho/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1131 - 1132. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Davis, E. Pagnin, A. Semplicini, A. Avogaro, and L. A. Calo Insulin Signaling, Glucose Metabolism, and the Angiotensin II Signaling System: Studies in Bartter's/Gitelman's syndromes Diabetes Care, February 1, 2006; 29(2): 469 - 471. [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Calo, E. Pagnin, P. A. Davis, M. Sartori, A. Semplicini, A. C. Pessina, S. Wolfrum, Y. Rikitake, J. K. Liao, A. Dendorfer, et al. Rho Kinase Inhibition and Vascular Protection: Support From Studies in Bartter and Gitelman Syndrome Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): e34 - e35. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Pagnin, G. Fadini, R. de Toni, A. Tiengo, L. Calo, and A. Avogaro Diabetes Induces p66shc Gene Expression in Human Peripheral Blood Mononuclear Cells: Relationship to Oxidative Stress J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|